Biotech · Private company
RxSight, Inc.
Track this companyFree. Adds RxSight, Inc. to your Dealase workspace and tells you when its record changes.
Clinical trials50 recruiting or active
Pipeline programs7From trials and the company's site
Disclosed deals0None found yet
Cash runwayNot availablePrivate: no SEC financials
Pipeline7
- Control IOLAphakiaClinicalTrials.gov · fetched Nov 12, 2026
- Light Adjustable lens (LAL) and Light Delivery Device (LDD)AphakiaClinicalTrials.gov · fetched Nov 12, 2026
- Light Adjustable lens (LAL) and Light Delivery Device (LDD)Aphakia CataractClinicalTrials.gov · fetched Nov 12, 2026
- Light Adjustable lens (LAL) and Light Delivery Device (LDD) - Pre-COVID PopulationAphakiaClinicalTrials.gov · fetched Nov 12, 2026
- Light Delivery Device (LDD)AphakiaClinicalTrials.gov · fetched Nov 12, 2026
- SofPort LI61AO IOLAphakiaClinicalTrials.gov · fetched Nov 12, 2026
- Tecnis ZCB00 or ZTC150 IOLAphakiaClinicalTrials.gov · fetched Nov 12, 2026
Clinical trials5
- Long-Term Clinical Outcomes Of Subjects Enrolled In The RxSight Light Adjustable Lens (LAL) And Light Delivery Device (LDD) New Enrollment StudyCOMPLETED · started Nov 13, 2025ClinicalTrials.gov NCT07347379 · fetched Nov 12, 2026
- RxSight Light Adjustable Lens and Light Delivery Device New Enrollment StudyNA · COMPLETED · started Dec 3, 2021ClinicalTrials.gov NCT05202808 · fetched Nov 12, 2026
- A Clinical Study to Evaluate The Safety and Effectiveness of The RxSight Light Adjustable Lens (LAL) In Subjects Desiring an Extended Depth of FocusTERMINATED · started Nov 15, 2019ClinicalTrials.gov NCT04177771 · fetched Nov 12, 2026
- A Clinical Study to Evaluate The Safety and Effectiveness of Performing 0.50 Diopter Astigmatism Correction on the Commercially Available RxSight Light Adjustable Lens (LAL)NA · COMPLETED · started Jul 1, 2019ClinicalTrials.gov NCT04005586 · fetched Nov 12, 2026
- Clinical Study to Evaluate the Safety and Effectiveness of the RxSight Light Adjustable Lens (LAL) in Subjects With Prior Corneal Refractive SurgeryNA · COMPLETED · started Aug 28, 2018ClinicalTrials.gov NCT03660865 · fetched Nov 12, 2026